Global Primary Angle-Closure Glaucoma Market – Industry Trends and Forecast to 2031

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Primary Angle-Closure Glaucoma Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Mar 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Primary Angle-Closure Glaucoma Market, By Disease Type (Acute Angle-Closure Glaucoma and Chronic Angle-Closure Glaucoma), Type (Diagnosis and Treatment), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others) - Industry Trends and Forecast to 2031.

 Primary Angle-Closure Glaucoma Market

Primary Angle-Closure Glaucoma Market Analysis and Size

The global primary angle-closure glaucoma market addresses the rising incidence of primary angle-closure glaucoma worldwide. This market encompasses pharmaceuticals, surgical interventions, and diagnostic tools aimed at managing and treating this sight-threatening condition. Innovations in medication and surgical techniques within this market contribute to improved patient outcomes, emphasizing the importance of early detection and intervention to prevent vision loss associated with primary angle-closure glaucoma.

Data Bridge Market Research analyses the global primary angle-closure glaucoma market, which was USD 253.48 million in 2023, is expected to reach USD 407.07 million by 2031, at a CAGR of 6.1% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Primary Angle-Closure Glaucoma Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2024-2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Disease Type (Acute Angle-Closure Glaucoma and Chronic Angle-Closure Glaucoma), Type (Diagnosis and Treatment), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others)

Countries Covered

U.S., Canada, Mexico, Germany, France, Italy U.K., Spain, Russia, Austria, Netherlands, Hungary, Poland, Switzerland, Turkey, Norway, Lithuania, Ireland, Rest of Europe, Japan, China, India, Australia, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Egypt, Saudi Arabia, Israel, U.A.E., Kuwait, Rest of Middle East and Africa

Market Players Covered

Johnson & Johnson Vision Care, Inc. (U.S.), Aurolab (India), New World Medical, Inc. (U.S.), Sight Sciences (U.S.), NIDEK CO., LTD (Japan), BVI (U.S.), MicroSurgical Technology (U.S.), Bausch + Lomb (U.S.), Oertli Instrumente AG (Switzerland), Medisonic Equipments Pvt. Ltd. (India), Omni Lens Pvt. Ltd. (U.S.), Appasamy Associates Private Limited (India), NOVAEYE MEDICAL (Australia), ZEISS Group (Germany), Alcon Inc. (Switzerland), LIGHTMED (Taiwan), Reichert, Inc. (U.S.), NewVision Softcom & Consultancy Pvt. Ltd

Market Opportunities

  • Market Expansion Enhances Awareness among the Population
  • Personalized Medicine for Targeted Therapies

Market Definition

Primary angle-closure glaucoma is a type of glaucoma characterized by the gradual or sudden blockage of the drainage angle within the eye, leading to impaired fluid drainage and increased intraocular pressure. This elevated pressure can damage the optic nerve, resulting in vision loss. Symptoms may include severe eye pain, headache, blurred vision, and nausea. Timely diagnosis and intervention are crucial to prevent irreversible vision impairment, often requiring medical or surgical interventions to alleviate intraocular pressure and manage the condition.

Global Primary Angle-Closure Glaucoma Market Dynamics

Drivers

  • Increased Awareness among the Aging Population

The aging population is more susceptible to glaucoma, including primary angle-closure glaucoma. With a global rise in life expectancy, there is an expanding number of individuals at risk. This demographic shift creates an opportunity for the market to cater to the increasing demand for glaucoma diagnostics, monitoring, and treatment options. Heightened awareness campaigns about eye health and regular screenings contribute to early detection and treatment, providing a fertile ground for market growth.

  • Growing Incidence of Diabetes and Hypertension Develops the Risk of Glaucoma

Diabetes and hypertension are known risk factors for glaucoma, including primary angle-closure glaucoma. With the global surge in the prevalence of diabetes and hypertension, there is a corresponding increase in the number of individuals at risk of developing glaucoma. This rising patient number contributes to the expansion of the primary angle-closure glaucoma market as healthcare providers focus on addressing the ocular health needs of this demographic.

Opportunities

  • Market Expansion Enhances Awareness among the Population

 Opportunities lie in expanding the market globally, especially in regions with high prevalence rates of primary angle-closure glaucoma. Companies that focus on establishing a strong presence in emerging markets and collaborating with healthcare providers to enhance awareness and accessibility provides the new patient populations. The potential for substantial market growth and improved patient outcomes by addressing the unmet needs in these regions.

  • Personalized Medicine for Targeted Therapies

 The trend towards personalized medicine presents an opportunity for the primary angle-closure glaucoma market. Tailoring treatment approaches based on individual patient characteristics, genetic factors, and disease progression can enhance the effectiveness of interventions. Companies investing in research to develop targeted therapies and precision medicine solutions for primary angle-closure glaucoma may gain a competitive edge in providing more efficient and personalized care, driving advancements in the field.

Restraints/Challenges

  • Consumers Facing Challenges in Affordability

Accessibility to advanced diagnostic tools and treatment options, coupled with financial constraints in some regions, can pose a significant restraint on the primary angle-closure glaucoma market. Patients in certain areas may face challenges in accessing specialized eye care services or affording expensive glaucoma medications or surgical interventions, limiting the market's growth potential in those regions.

  • Tolerability of Medications among Consumers

The global primary angle-closure glaucoma market is associated with the potential adverse effects and tolerability issues related to medications commonly prescribed for managing intraocular pressure. Some patients may experience side effects that affect their quality of life or necessitate changes in treatment plans. These challenges in medication tolerability can lead to non-compliance and discontinuation, impacting the overall effectiveness of treatment strategies and potentially hindering market growth.

This global primary angle-closure glaucoma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global primary angle-closure glaucoma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In December 21, Aerie Pharmaceuticals collaborated with Santen Pharmaceuticals, announced in December 2021, focuses on the development and marketing of glaucoma therapy products, including Rhopressa/Rhokiinsa and Rocklatan/Roclanda. This collaboration aims to strengthen both companies' market presence in regions such as India, Europe, Oceania, China, and parts of Latin America, fostering a global expansion of their glaucoma treatment offerings
  • In March 2021, Teva Pharmaceuticals bolstered its product portfolio by introducing the first generic version of AZOPT (brinzolamide ophthalmic suspension) 1 percent in the U.S. This move enhances Teva's capabilities in addressing open-angle glaucoma and ocular hypertension, contributing to its position in the pharmaceutical market for ocular conditions
  • In June 2020, Johnson & Johnson Vision Care, Inc. demonstrated its commitment to supporting eye care during the COVID-19 pandemic by announcing a generous donation of USD 0.30 million. The funds were allocated to Optometry Cares – The American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation. This donation aimed to assist practitioners in their efforts to provide essential eye care services to communities affected by the pandemic, underscoring the company's dedication to promoting eye health during challenging times

Global Primary Angle-Closure Glaucoma Market Scope

The global primary angle-closure glaucoma market is segmented on the basis of the disease type, type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Disease Type

  • Acute Angle-Closure Glaucoma
  • Chronic Angle-Closure Glaucoma

Type

  • Diagnosis
  • Treatment

End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Others

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Others

Global Primary Angle-Closure Glaucoma Market Regional Analysis/Insights

The global primary angle-closure glaucoma market is analysed and market size information is provided by the country, disease type, type, end user and distribution channel as referenced above.

The countries covered in the global primary angle-closure glaucoma market report are the U.S., Canada, Mexico, Germany, France, Italy U.K., Spain, Russia, Austria, Netherlands, Hungary, Poland, Switzerland, Turkey, Norway, Lithuania, Ireland, rest of Europe, Japan, China, India, Australia, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, South Africa, Egypt, Saudi Arabia, Israel, U.A.E., Kuwait and rest of Middle East and Africa.

North America is expected to dominate the primary angle-closure glaucoma market, primarily attributed to its status as the largest consumer market with a robust GDP. The U.S., boasting the highest household spending globally, emerges as a key player. The region exhibits elevated rates in both the diagnosis and treatment segments, solidifying its position as the primary market for products related to primary angle-closure glaucoma.

Europe is expected to experience the highest CAGR in the forecasted period, attributed to extensive research initiatives underway in Germany. The region benefits from advanced healthcare infrastructure, particularly in the diagnosis segment, enhancing its growth potential. With a robust foundation for medical studies and superior healthcare facilities, Europe stands as a key hub for advancements in the healthcare sector, contributing to anticipated growth in the coming years.

The Asia-Pacific is expected to experience significant growth, driven by shifting lifestyles and increasing urbanization. Japan, a global leader, is anticipated to dominate the market within the region due to a substantial rise in product usage and diagnosis rates, particularly in the context of primary angle-closure glaucoma. The rapid increase in awareness regarding this condition further contributes to Japan's prominence in the market, positioning it as a key player in the evolving landscape of eye care in the Asia-Pacific.

The Middle East and Africa region are expected to experience significant growth from 2024-2031, driven by a substantial increase in awareness about the target disease within these countries. The forecasted growth is attributed to the rising consciousness and understanding of the particular ailment in the region. This increased awareness is likely to contribute to higher demand for healthcare solutions, leading to the projected expansion of the pharmaceutical and healthcare sectors in the Middle East and Africa.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The global primary angle-closure glaucoma market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global primary angle-closure glaucoma market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global primary angle-closure glaucoma market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Primary Angle-Closure Glaucoma Market Share Analysis

The global primary angle-closure glaucoma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global primary angle-closure glaucoma market.

Some of the major players operating in the global primary angle-closure glaucoma market are:

  • Johnson & Johnson Vision Care, Inc. (U.S.)
  • Aurolab (India)
  • New World Medical, Inc. (U.S.)
  • Sight Sciences (U.S.)
  • NIDEK CO., LTD (Japan)
  • BVI (U.S.)
  • MicroSurgical Technology (U.S.)
  • Bausch + Lomb (U.S.)
  • Oertli Instrumente AG (Switzerland)
  • Medisonic Equipments Pvt. Ltd. (India)
  • Omni Lens Pvt. Ltd. (U.S.)
  • Appasamy Associates Private Limited (India)
  • NOVAEYE MEDICAL (Australia)
  • ZEISS Group (Germany)
  • Alcon Inc. (Switzerland)
  • LIGHTMED (Taiwan)
  • Reichert, Inc. (U.S.)
  • NewVision Softcom & Consultancy Pvt. Ltd (India) 


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end user coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. Regulatory Framework
  6. Pipeline analysis
  7. market overview
    1. drivers
      1. INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA
      2. INCREASING WOMEN POPULATION
      3. RISE IN GERIATRIC POPULATION
      4. ADVANCEMENTS IN SURGICAL TREATMENT OF THE DISEASE
      5. INCREASED ECONOMIC BURDEN
    2. RESTRAINTS
      1. HIGH SURGICAL COSTS OF PACG
      2. INADEQUATE REIMBURSEMENT SCENARIO
      3. DELAYED AND MISDIAGNOSIS OF PACG
    3. OPPORTUNITIES
      1. INCREASING GOVERNMENT INITIATIVES TOWARDS GLAUCOMA
      2. RECENT APPROVAL BY GOVERNING BODIES
      3. INCREASING INCIDENCES IN EMERGING MARKET
      4. RAPID TRANSITION FROM PACG MEDICATION TO SURGERIES
    4. CHALLENGES
      1. RISKS ASSOCIATED WITH SURGICAL PROCEDURES
      2. LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
      3. LIMITED ACCESS TO TREATMENT
  8. IMPACT OF COVID-19 ON GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS
    5. CONCLUSION
  9. global PRIMARY ANGLE CLOSURE GLAUCOMA Market, By DISEASE TYPE
    1. overview
    2. acute angle-closure glaucoma market
    3. chronic angle-closure glaucoma market
  10. GLOBAL primary angle-closure glaucoma MARKET, BY TYPE
    1. overview
    2. Diagnosis
      1. primary test
        1. GONIOSCOPY EXAMINATION
        2. SLIT-LAMP EXAMINATION
        3. AUTOMATIC STATIC PERIMETRY
      2. SECONDARY test
        1. ULTRASOUND BIOMICROSCOPY
        2. ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY (OCT)
        3. RETINAL OCT
        4. FUNDOSCOPY
        5. OTHERS
    3. Treatment
      1. Surgical Iridectomy
      2. TRABECULECTOMY
      3. Micro invasive glaucoma technique (MIGS)
      4. goniotomy
      5. Others
  11. GLOBAL primary angle-closure glaucoma MARKET, BY end user
    1. overview
    2. HoSpitals
    3. AMbulatory surgical Centers
    4. Specialty Clinics
    5. others
  12. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail sales
    4. Others
  13. GLOBAL primary angle-closure glaucoma MARKET, BY GEOGRAPHY
    1. OVERVIEW
    2. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. FRANCE
      3. ITALY
      4. U.K.
      5. SPAIN
      6. RUSSIA
      7. AUSTRIA
      8. NETHERLANDS
      9. HUNGARY
      10. POLAND
      11. SWITZERLAND
      12. TURKEY
      13. NORWAY
      14. LITHUANIA
      15. IRELAND
      16. REST OF EUROPE
    4. ASIA-PACIFIC
      1. JAPAN
      2. CHINA
      3. INDIA
      4. AUSTRALIA
      5. SINGAPORE
      6. SOUTH KOREA
      7. MALAYSIA
      8. THAILAND
      9. INDONESIA
      10. PHILIPPINES
      11. VIETNAM
      12. REST OF ASIA-PACIFIC
    5. SOuth america
      1. BRAZIL
      2. ARGENTINA
      3. PERU
      4. REST OF SOUTH AMERICA
    6. middle east and Africa
      1. SOUTH AFRICA
      2. EGYPT
      3. SAUDI ARABIA
      4. ISRAEL
      5. UAE
      6. KUWAIT
      7. REST OF MIDDLE EAST AND AFRICA
  14. Global primary angle-closure glaucoma Market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  15. SWOT
  16. company profiles
    1. johnson & johnson vision care, inc. (a subsidiary of johnson & johnson services, inc.)
      1. COMPANY SNAPSHot
      2. Revenue analysis
      3. company share analysis
      4. product Portfolio
      5. RECENT DEVELOPMENTS
    2. bausch & lomb incorporated (a subsidiary of bausch health Companies Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. alcon inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Zeiss International
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. NOVA EYE MEDICAL LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. NIDEK CO., LTD
      1. COMPANY SNAPShot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    7. allergan (a subsidiary of abbvie inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    8. APPASAMY ASSOCIATES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. aurolab
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. BVI
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    11. LIGHTMED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Luneau technology usa
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. medisonic equipments pvt. ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. microsurgical technology
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    15. new vision
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. New World Medical, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. Oertli Instrumente AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. omni lens
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. Reichert, inc. (A business unit of ametek.inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    20. Sight Sciences, inc.
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
  17. questionnaire
  18. related reports

List of Table

TABLE 1 Global Primary Angle-Closure Glaucoma Market, Pipeline Analysis

TABLE 2 NUMBER OF OPHTHALMOLOGISTS/MILLION POPULATIONS

TABLE 3 global Primary angle closure glaucoma market, By disease type, 2019-2028 (USD million)

TABLE 4 Global Acute-angle closure glaucoma in Primary angle closure glaucoma Market, By Region, 2019-2028 (USD Million)

TABLE 5 Global chronic angle-closure glaucoma in Primary angle closure glaucoma Market,By Region, 2019-2028 (USD Million)

TABLE 6 Global Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 7 Global Diagnosis in Primary Angle-Closure Glaucoma Market, By region, 2019-2028 (USD Million)

TABLE 8 Global Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 9 Global Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 10 Global Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 11 Global Treatment in Primary Angle-Closure Glaucoma Market, By Disease Type 2019-2028 (USD Million)

TABLE 12 Global Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 13 Global Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 14 Global Hospitals in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 15 Global Ambulatory Surgical Centers in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 16 Global Specialty Clinics in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 17 Global Others in Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 18 Global Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 19 Global Direct Tender in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 20 Global Retail Sales in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 21 Global Others in Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 22 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)

TABLE 24 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 25 North America Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 26 North America Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 27 North America Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 28 North America Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 29 North America Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 30 North America Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 31 North America Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 32 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 33 U.S. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 34 U.S. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 35 U.S. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 36 U.S. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 37 U.S. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 38 U.S. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 39 U.S. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 40 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 41 CANADA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 42 CANADA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 43 CANADA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 44 CANADA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 45 CANADA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 46 CANADA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 47 CANADA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 48 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 49 MEXICO Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 50 MEXICO Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 51 MEXICO Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 52 MEXICO Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 53 MEXICO Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 54 MEXICO Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 55 MEXICO Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)

TABLE 57 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 58 EUROPE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 59 EUROPE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 60 EUROPE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 61 EUROPE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 62 EUROPE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 63 EUROPE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 64 EUROPE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 65 Germany PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 66 GERMANY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 67 GERMANY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 68 GERMANY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 69 GERMANY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 70 GERMANY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 71 GERMANY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 72 GERMANY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 73 FRANCE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 74 FRANCE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 75 FRANCE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 76 FRANCE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 77 FRANCE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 78 FRANCE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 79 FRANCE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 80 FRANCE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 81 ITALY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 82 ITALY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 83 ITALY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 84 ITALY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 85 ITALY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 86 ITALY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 87 ITALY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 88 ITALY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 89 U.K. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 90 U.K. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 91 U.K. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 92 U.K. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 93 U.K. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 94 U.K. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 95 U.K. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 96 U.K. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 97 SPAIN PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 98 SPAIN Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 99 SPAIN Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 100 SPAIN Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 101 SPAIN Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 102 SPAIN Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 103 SPAIN Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 104 SPAIN Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 105 RUSSIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 106 RUSSIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 107 RUSSIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 108 RUSSIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 109 RUSSIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 110 RUSSIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 111 RUSSIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 112 RUSSIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 113 AUSTRIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 114 AUSTRIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 115 AUSTRIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 116 AUSTRIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 117 AUSTRIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 118 AUSTRIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 119 AUSTRIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 120 AUSTRIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 121 NETHERLANDS PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 122 NETHERLANDS Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 123 NETHERLANDS Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 124 NETHERLANDS Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 125 NETHERLANDS Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 126 NETHERLANDS Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 127 NETHERLANDS Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 128 NETHERLANDS Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 129 HUNGARY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 130 HUNGARY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 131 HUNGARY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 132 HUNGARY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 133 HUNGARY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 134 HUNGARY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 135 HUNGARY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 136 HUNGARY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 137 POLAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 138 POLAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 139 POLAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 140 POLAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 141 POLAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 142 POLAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 143 POLAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 144 POLAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 145 SWITZERLAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 146 SWITZERLAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 147 SWITZERLAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 148 SWITZERLAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 149 SWITZERLAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 150 SWITZERLAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 151 SWITZERLAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 152 SWITZERLAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 153 TURKEY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 154 TURKEY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 155 TURKEY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 156 TURKEY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 157 TURKEY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 158 TURKEY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 159 TURKEY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 160 TURKEY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 161 NORWAY PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 162 NORWAY Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 163 NORWAY Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 164 NORWAY Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 165 NORWAY Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 166 NORWAY Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 167 NORWAY Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 168 NORWAY Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 169 LITHUANIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 170 LITHUANIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 171 LITHUANIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 172 LITHUANIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 173 LITHUANIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 174 LITHUANIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 175 LITHUANIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 176 LITHUANIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 177 IRELAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 178 IRELAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 179 IRELAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 180 IRELAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 181 IRELAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 182 IRELAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 183 IRELAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 184 IRELAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 185 REst of europe Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)

TABLE 186 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)

TABLE 187 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 188 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 189 ASIA-PACIFIC Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 190 ASIA-PACIFIC Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 191 ASIA-PACIFIC Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 192 ASIA-PACIFIC Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 193 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 194 ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 195 JAPAN PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 196 JAPAN Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 197 JAPAN Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 198 JAPAN Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 199 JAPAN Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 200 JAPAN Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 201 JAPAN Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 202 JAPAN Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 203 CHINA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 204 CHINA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 205 CHINA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 206 CHINA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 207 CHINA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 208 CHINA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 209 CHINA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 210 CHINA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 211 INDIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 212 INDIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 213 INDIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 214 INDIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 215 INDIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 216 INDIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 217 INDIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 218 INDIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 219 AUSTRALIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 220 AUSTRALIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 221 AUSTRALIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 222 AUSTRALIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 223 AUSTRALIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 224 AUSTRALIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 225 AUSTRALIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 226 AUSTRALIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 227 SINGAPORE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 228 SINGAPORE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 229 SINGAPORE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 230 SINGAPORE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 231 SINGAPORE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 232 SINGAPORE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 233 SINGAPORE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 234 SINGAPORE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 235 SOUTH KOREA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 236 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 237 SOUTH KOREA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 238 SOUTH KOREA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 239 SOUTH KOREA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 240 SOUTH KOREA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 241 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 242 SOUTH KOREA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 243 MALAYSIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 244 MALAYSIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 245 MALAYSIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 246 MALAYSIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 247 MALAYSIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 248 MALAYSIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 249 MALAYSIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 250 MALAYSIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 251 THAILAND PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 252 THAILAND Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 253 THAILAND Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 254 THAILAND Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 255 THAILAND Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 256 THAILAND Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 257 THAILAND Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 258 THAILAND Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 259 INDONESIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 260 INDONESIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 261 INDONESIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 262 INDONESIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 263 INDONESIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 264 INDONESIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 265 INDONESIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 266 INDONESIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 267 PHILIPPINES PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 268 PHILIPPINES Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 269 PHILIPPINES Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 270 PHILIPPINES Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 271 PHILIPPINES Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 272 PHILIPPINES Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 273 PHILIPPINES Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 274 PHILIPPINES Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 275 VIETNAM PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 276 VIETNAM Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 277 VIETNAM Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 278 VIETNAM Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 279 VIETNAM Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 280 VIETNAM Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 281 VIETNAM Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 282 VIETNAM Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 283 REst of ASIA-PACIFIC Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)

TABLE 284 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)

TABLE 285 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 286 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 287 SOUTH AMERICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 288 SOUTH AMERICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 289 SOUTH AMERICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 290 SOUTH AMERICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 291 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 292 SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 293 BRAZIL PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 294 BRAZIL Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 295 BRAZIL Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 296 BRAZIL Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 297 BRAZIL Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 298 BRAZIL Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 299 BRAZIL Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 300 BRAZIL Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 301 ARGENTINA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 302 ARGENTINA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 303 ARGENTINA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 304 ARGENTINA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 305 ARGENTINA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 306 ARGENTINA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 307 ARGENTINA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 308 ARGENTINA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 309 PERU PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 310 PERU Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 311 PERU Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 312 PERU Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 313 PERU Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 314 PERU Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 315 PERU Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 316 PERU Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 317 REst of SOUTH AMERICA Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)

TABLE 318 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)

TABLE 319 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 320 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 321 MIDDLE EAST AND AFRICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 322 MIDDLE EAST AND AFRICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 323 MIDDLE EAST AND AFRICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 324 MIDDLE EAST AND AFRICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 325 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 326 MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 327 SOUTH AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 328 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 329 SOUTH AFRICA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 330 SOUTH AFRICA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 331 SOUTH AFRICA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 332 SOUTH AFRICA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 333 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 334 SOUTH AFRICA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 335 EGYPT PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 336 EGYPT Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 337 EGYPT Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 338 EGYPT Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 339 EGYPT Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 340 EGYPT Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 341 EGYPT Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 342 EGYPT Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 343 SAUDI ARABIA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 344 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 345 SAUDI ARABIA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 346 SAUDI ARABIA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 347 SAUDI ARABIA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 348 SAUDI ARABIA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 349 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 350 SAUDI ARABIA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 351 ISRAEL PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 352 ISRAEL Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 353 ISRAEL Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 354 ISRAEL Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 355 ISRAEL Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 356 ISRAEL Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 357 ISRAEL Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 358 ISRAEL Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 359 UAE PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 360 UAE Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 361 UAE Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 362 UAE Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 363 UAE Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 364 UAE Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 365 UAE Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 366 UAE Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 367 KUWAIT PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 368 KUWAIT Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 369 KUWAIT Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 370 KUWAIT Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 371 KUWAIT Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 372 KUWAIT Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 373 KUWAIT Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 374 KUWAIT Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 375 REst of MIDDLE EAST AND AFRICA Primary Angle-Closure Glaucoma Market, By disease type, 2019-2028 (USD Million)

List of Figure

FIGURE 1 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: segmentation

FIGURE 2 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET : data triangulation

FIGURE 3 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DBMR MARKET POSITION GRID

FIGURE 9 Global primary angle-closure glaucoma market: MARKET end user coverage GRID

FIGURE 10 GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Global primary angle-closure glaucoma market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE and asia-pacific is growing at the fastest pace in global primary angle-closure glaucoma market IN the forecast period of 2021 to 2028

FIGURE 13 INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA and ADVANCEMENT IN SURGICAL TREATMENT OF THE DISEASE are DRIVing THE global primary angle-closure glaucoma market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 ACUTE ANGLE-CLOSURE GLAUCOMA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET IN 2021 & 2028

FIGURE 15 asia-PACIFIC is the fastest growing market in global primary angle-closure glaucoma market in the forecast period of 2021 to 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET

FIGURE 17 global Primary angle closure glaucoma market: By disease type, 2020

FIGURE 18 global Primary angle closure glaucoma market: By disease type, 2020-2028 (USD Million)

FIGURE 19 global Primary angle closure glaucoma market: By disease type, CAGR (2020-2028)

FIGURE 20 global Primary angle closure glaucoma market: By disease type, LIFELINE CURVE

FIGURE 21 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, 2020

FIGURE 22 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE 2020-2028 (USD Million)

FIGURE 23 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, CAGR (2021-2028)

FIGURE 24 global PROSTATE CANCER DIAGNOSTICS market: BY TYPE, LIFELINE CURVE

FIGURE 25 global Primary Angle-Closure Glaucoma market: BY end users, 2020

FIGURE 26 global Primary Angle-Closure Glaucoma market: BY end users, 2020-2028 (USD Million)

FIGURE 27 global Primary Angle-Closure Glaucoma market: BY end users, CAGR (2021-2028)

FIGURE 28 global Primary Angle-Closure Glaucoma market: BY end users, LIFELINE CURVE

FIGURE 29 global Primary Angle-Closure Glaucoma market: BY distribution channel, 2020

FIGURE 30 global Primary Angle-Closure Glaucoma market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 31 global Primary Angle-Closure Glaucoma market: BY distribution channel, CAGR (2021-2028)

FIGURE 32 global Primary Angle-Closure Glaucoma market: BY distribution, LIFELINE CURVE

FIGURE 33 GLobal PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)

FIGURE 34 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)

FIGURE 35 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 36 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 37 global PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2020-2028)

FIGURE 38 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)

FIGURE 39 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)

FIGURE 40 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)

FIGURE 41 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 42 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)

FIGURE 43 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)

FIGURE 44 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)

FIGURE 45 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)

FIGURE 46 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 EUROPE PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)

FIGURE 48 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)

FIGURE 49 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)

FIGURE 50 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)

FIGURE 51 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 52 ASIA-PACIFIC PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)

FIGURE 53 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)

FIGURE 54 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)

FIGURE 55 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)

FIGURE 56 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 57 SOUTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)

FIGURE 58 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)

FIGURE 59 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)

FIGURE 60 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)

FIGURE 61 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 62 MIDDLE EAST AND AFRICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)

FIGURE 63 Global primary angle-closure glaucoma market: company share 2020 (%)

FIGURE 64 north america primary angle-closure glaucoma market: company share 2020 (%)

FIGURE 65 europe primary angle-closure glaucoma market: company share 2020 (%)

FIGURE 66 Asia-Pacific primary angle-closure glaucoma market: company share 2020 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Primary Angle-Closure Glaucoma Market size will be worth USD 407.07 million by 2031 during the forecast period.
The Primary Angle-Closure Glaucoma Market growth rate is 6.1% during the forecast period.
The Increased Awareness among the Aging Population and the Growing Incidence of Diabetes and Hypertension Develops the Risk of Glaucoma are the growth drivers of the Primary Angle-Closure Glaucoma Market.
The disease type, type, end user, and distribution channel are the factors on which the Primary Angle-Closure Glaucoma Market research is based.
The major companies in the Primary Angle-Closure Glaucoma Market are Johnson & Johnson Vision Care, Inc. (U.S.), Aurolab (India), New World Medical, Inc. (U.S.), Sight Sciences (U.S.), NIDEK CO., LTD (Japan), BVI (U.S.), MicroSurgical Technology (U.S.), Bausch + Lomb (U.S.), Oertli Instrumente AG (Switzerland), Medisonic Equipments Pvt. Ltd. (India), Omni Lens Pvt. Ltd. (U.S.), Appasamy Associates Private Limited (India), NOVAEYE MEDICAL (Australia), ZEISS Group (Germany), Alcon Inc. (Switzerland), LIGHTMED (Taiwan), Reichert, Inc. (U.S.), NewVision Softcom & Consultancy Pvt. Ltd.